Use of medicines and other products for therapeutic purposes among children in brazil

Show simple item record

dc.contributor.author Dal Pizzol, Tatiane da Silva
dc.contributor.author Leao Tavares, Noemia Urruth
dc.contributor.author Bertoldi, Andrea Damaso
dc.contributor.author Farias, Mareni Rocha
dc.contributor.author Dourado Arrais, Paulo Sergio
dc.contributor.author Ramos, Luiz Roberto [UNIFESP]
dc.contributor.author Oliveira, Maria Auxiliadora
dc.contributor.author Luiza, Vera Lucia
dc.contributor.author Mengue, Sotero Serrate
dc.date.accessioned 2019-01-21T10:29:35Z
dc.date.available 2019-01-21T10:29:35Z
dc.date.issued 2016
dc.identifier http://dx.doi.org/10.1590/s1518-8787.2016050006115
dc.identifier.citation Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 12s, 2016.
dc.identifier.issn 0034-8910
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/49279
dc.description.abstract OBJECTIVE: To assess the prevalence of the use of medicines and other products for therapeutic purposes in the Brazilian pediatric population and test whether demographic, socioeconomic and health factors are associated with use. METHODS: A cross-sectional population-based study (National Survey on Access, Use and Promotion of Rational Use of Medicines - PNAUM), including 7,528 children aged 12 or younger, living in urban areas in Brazil. Medicine use to treat chronic or acute diseases was reported by the primary caregiver present at the household interview. Associations between independent variables and medicine use were investigated by Poisson regression. RESULTS: The overall prevalence of medicine use was 30.7% (95% CI 28.3-33.1). The prevalence of medicine use for chronic diseases was 5.6% (95% CI 4.7-6.7) and for acute conditions, 27.1% (95% CI 24.8-29.4). The factors significantly associated with overall use were five years old or under, living in the Northeast region, having health insurance and using health services in the last 12 months (emergency visits and hospitalizations). The following were associated with drug use for chronic diseases: age >= 2 years, Southeast and South regions, and use of health services. For drug use in treating acute conditions, the following associated factors were identified: <= 5 years, North, Northeast or Midwest regions, health insurance, and one or more emergency visits. The most commonly used drugs among children under two years of age were paracetamol, ascorbic acid, and dipyrone en
dc.description.abstract for children aged two years or over they were dipyrone, paracetamol, and amoxicillin. CONCLUSIONS: The use of medicine by children is considerable, especially in treating acute medical conditions. Children using drugs for chronic diseases have a different demographic profile from those using drugs for acute conditions in relation to gender, age, and geographic region. en
dc.description.sponsorship Department for Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs - SCTIE of the Ministry of Health [25000.111834/2011-31]
dc.description.sponsorship Department of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs - SCTIE of the Ministry of Health [25000.111834/2011-31]
dc.format.extent 12s
dc.language.iso eng
dc.publisher Iop Publishing Ltd
dc.relation.ispartof Revista De Saude Publica
dc.rights Acesso aberto
dc.subject Drug-Use en
dc.subject Medication Use en
dc.subject Metaanalysis en
dc.subject Adolescents en
dc.subject Resistance en
dc.subject Age en
dc.title Use of medicines and other products for therapeutic purposes among children in brazil en
dc.title Uso de medicamentos e outros produtos com finalidade terapêutica entre crianças no Brasil pt
dc.type Artigo
dc.description.affiliation Departamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliation Departamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliation Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliation Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliation Departamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliation Programa de Pós-Graduação em Epidemiologia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliationUnifesp Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sponsorshipID SCTIE: 25000.111834/2011-31
dc.identifier.file S0034-89102016000300312.pdf
dc.identifier.scielo S0034-89102016000300312
dc.identifier.doi 10.1590/S1518-8787.2016050006115
dc.description.source Web of Science
dc.identifier.wos WOS:000391447400001



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account